PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
33148101-0	2022	miR-362-3p suppresses sinonasal squamous cell carcinoma progression via directly targeting pituitary tumor-transforming gene 1.	mir-362-3p	0-10	PTTG1 regulator of sister chromatid separation, securin	Homo sapiens	91-126
34839107-7	2022	RESULTS: miR-362-3p expression levels were decreased in ovarian cancer tissues and cells and negatively correlated with LRP8 levels.	mir-362-3p	9-19	LDL receptor related protein 8	Homo sapiens	120-124
34839107-9	2022	Furthermore, overexpression of LRP8 significantly facilitated the proliferation, migration, and invasion of ovarian cancer cells, which counteracted the inhibitory effect of miR-362-3p on ovarian cancer cell growth.	mir-362-3p	174-184	LDL receptor related protein 8	Homo sapiens	31-35
33526047-0	2021	miR-362-3p acts as a tumor suppressor by targeting SERBP1 in ovarian cancer.	mir-362-3p	0-10	SERPINE1 mRNA binding protein 1	Homo sapiens	51-57
33526047-14	2021	miR-362-3p inhibits the development and progression of ovarian cancer by directly binding its target gene SERBP1.	mir-362-3p	0-10	SERPINE1 mRNA binding protein 1	Homo sapiens	106-112
34839107-0	2022	miR-362-3p suppresses ovarian cancer by inhibiting LRP8.	mir-362-3p	0-10	LDL receptor related protein 8	Homo sapiens	51-55
35115787-11	2022	Moreover, miR-362-3p inhibited the proliferation, migration and invasion of both EBV-positive and -negative NPC cells, and these effects might be mediated by targeting JMJD2A.	mir-362-3p	10-20	lysine demethylase 4A	Homo sapiens	168-174
33459949-0	2021	miR-362-3p Targets Orosomucoid 1 to Promote Cell Proliferation, Restrain Cell Apoptosis and Thereby Mitigate Hypoxia/Reoxygenation-Induced Cardiomyocytes Injury.	mir-362-3p	0-10	orosomucoid 1	Homo sapiens	19-32
33459949-5	2021	The promoting influence of miR-362-3p mimic on the proliferation and the inhibitory effect of miR-362-3p mimic on the apoptosis of H/R-stimulated cardiomyocytes were eliminated by overexpression of ORM1.	mir-362-3p	27-37	orosomucoid 1	Homo sapiens	198-202
33459949-5	2021	The promoting influence of miR-362-3p mimic on the proliferation and the inhibitory effect of miR-362-3p mimic on the apoptosis of H/R-stimulated cardiomyocytes were eliminated by overexpression of ORM1.	mir-362-3p	94-104	orosomucoid 1	Homo sapiens	198-202
33459949-6	2021	Furthermore, miR-362-3p affected the expression of MAPK1, MAPK3, IL1B and CASP9 in H/R-injured cardiomyocytes through targeting ORM1.	mir-362-3p	13-23	mitogen-activated protein kinase 1	Homo sapiens	51-56
33459949-6	2021	Furthermore, miR-362-3p affected the expression of MAPK1, MAPK3, IL1B and CASP9 in H/R-injured cardiomyocytes through targeting ORM1.	mir-362-3p	13-23	mitogen-activated protein kinase 3	Homo sapiens	58-63
33459949-6	2021	Furthermore, miR-362-3p affected the expression of MAPK1, MAPK3, IL1B and CASP9 in H/R-injured cardiomyocytes through targeting ORM1.	mir-362-3p	13-23	interleukin 1 beta	Homo sapiens	65-69
33459949-6	2021	Furthermore, miR-362-3p affected the expression of MAPK1, MAPK3, IL1B and CASP9 in H/R-injured cardiomyocytes through targeting ORM1.	mir-362-3p	13-23	caspase 9	Homo sapiens	74-79
33459949-6	2021	Furthermore, miR-362-3p affected the expression of MAPK1, MAPK3, IL1B and CASP9 in H/R-injured cardiomyocytes through targeting ORM1.	mir-362-3p	13-23	orosomucoid 1	Homo sapiens	128-132
33459949-7	2021	Our outcomes illustrated that miR-362-3p exhibited a protective influence on H/R-induced cardiomyocytes through targeting ORM1.	mir-362-3p	30-40	orosomucoid 1	Homo sapiens	122-126
33515352-11	2021	Moreover, miR-362-3p was a target of SNHG1, miR-362-3p targeted Jak2 and negatively regulated Jak2/stat3 pathway.	mir-362-3p	10-20	Janus kinase 2	Rattus norvegicus	64-68
33515352-11	2021	Moreover, miR-362-3p was a target of SNHG1, miR-362-3p targeted Jak2 and negatively regulated Jak2/stat3 pathway.	mir-362-3p	10-20	Janus kinase 2	Rattus norvegicus	94-98
33515352-11	2021	Moreover, miR-362-3p was a target of SNHG1, miR-362-3p targeted Jak2 and negatively regulated Jak2/stat3 pathway.	mir-362-3p	10-20	signal transducer and activator of transcription 3	Rattus norvegicus	99-104
33148101-15	2022	CONCLUSION: miR-362-3p repressed cell proliferation, migration, invasion and EMT in SNSCC via targeting PTTG1.	mir-362-3p	12-22	PTTG1 regulator of sister chromatid separation, securin	Homo sapiens	104-109
32671239-10	2020	miR-362-3p inhibited cell proliferation and migration, bound the 3"-untranslated region (UTR) of MyD88, and inhibited MyD88 expression.	mir-362-3p	0-10	MYD88 innate immune signal transduction adaptor	Homo sapiens	97-102
32671239-10	2020	miR-362-3p inhibited cell proliferation and migration, bound the 3"-untranslated region (UTR) of MyD88, and inhibited MyD88 expression.	mir-362-3p	0-10	MYD88 innate immune signal transduction adaptor	Homo sapiens	118-123
32364763-11	2020	These results demonstrate that E2F1-induced overexpression of SBF2-AS1 promotes the expression of GRB2 by targeting miR-362-3p to facilitate the metastasis of NSCLC.	mir-362-3p	116-126	E2F transcription factor 1	Homo sapiens	31-35
32364763-11	2020	These results demonstrate that E2F1-induced overexpression of SBF2-AS1 promotes the expression of GRB2 by targeting miR-362-3p to facilitate the metastasis of NSCLC.	mir-362-3p	116-126	SBF2 antisense RNA 1	Homo sapiens	62-70
32364763-11	2020	These results demonstrate that E2F1-induced overexpression of SBF2-AS1 promotes the expression of GRB2 by targeting miR-362-3p to facilitate the metastasis of NSCLC.	mir-362-3p	116-126	growth factor receptor bound protein 2	Homo sapiens	98-102
32472295-8	2020	Moreover, miR-362-3p deletion attenuated the cytoprotective effects of curcumin by regulating TLR4 expression in LPS-induced BV2 cells.	mir-362-3p	10-20	toll-like receptor 4	Mus musculus	94-98
32582765-11	2020	Our results suggest that miR-362-3p inhibits migration and invasion via directly targeting BCAP31 in cervical cancer, and restoring miR-362-3p levels may be a new treatment strategy for cervical cancer in the future.	mir-362-3p	25-35	B cell receptor associated protein 31	Homo sapiens	91-97
31167206-3	2019	OBJECTIVES: This study aimed to elucidate pathobiological functions of miR-362-3p by targeting PAX3 in glioma.	mir-362-3p	71-81	paired box 3	Homo sapiens	95-99
31167206-10	2019	In addition, miR-362-3p also exhibited suppressive effect on epithelial-mesenchymal transition and Wnt/beta-catenin pathway.	mir-362-3p	13-23	catenin beta 1	Homo sapiens	103-115
31167206-12	2019	MiR-362-3p played a role in the suppressive effect on glioma by targeting PAX3 through suppressing Wnt/beta-catenin pathway.	mir-362-3p	0-10	paired box 3	Homo sapiens	74-78
31167206-12	2019	MiR-362-3p played a role in the suppressive effect on glioma by targeting PAX3 through suppressing Wnt/beta-catenin pathway.	mir-362-3p	0-10	catenin beta 1	Homo sapiens	103-115
32432112-0	2020	SP1/AKT/FOXO3 Signaling Is Involved in miR-362-3p-Mediated Inhibition of Cell-Cycle Pathway and EMT Progression in Renal Cell Carcinoma.	mir-362-3p	39-49	AKT serine/threonine kinase 1	Homo sapiens	4-7
32432112-0	2020	SP1/AKT/FOXO3 Signaling Is Involved in miR-362-3p-Mediated Inhibition of Cell-Cycle Pathway and EMT Progression in Renal Cell Carcinoma.	mir-362-3p	39-49	forkhead box O3	Homo sapiens	8-13